Abstract
Although some myokines exert their actions on other organs in a hormone–like fashion, many of them operate locally on skeletal muscle themselves. Myokines may thereby provide a feedback loop for the muscle to regulate its own growth and regeneration allowing for adaptation to exercise training. The myokine concept provides a conceptual basis and a whole new paradigm for understanding how muscles communicate with other organs within the muscle itself. New biotechnological patents are published based on the identification of new myokines, and these myokines and their receptors will potentially serve as pharmacological targets for treating muscle diseases, metabolic disorders and other diseases associated with muscle disuse.
Keywords: Skeletal muscle, exercise, metabolism, metabolic diseases, activity, inactivity, muscle, muscle cells, myoblasts, myocytes, myogenesis, cytokines, myokines, interleukins, IL-6, irisin, muscle wasting, muscular dystrophies, sarcopenia, patents
Recent Patents on Biotechnology
Title:Myokines in Myogenesis and Health
Volume: 6 Issue: 3
Author(s): Tora Henriksen, Charlotte Green and Bente Klarlund Pedersen
Affiliation:
Keywords: Skeletal muscle, exercise, metabolism, metabolic diseases, activity, inactivity, muscle, muscle cells, myoblasts, myocytes, myogenesis, cytokines, myokines, interleukins, IL-6, irisin, muscle wasting, muscular dystrophies, sarcopenia, patents
Abstract: Although some myokines exert their actions on other organs in a hormone–like fashion, many of them operate locally on skeletal muscle themselves. Myokines may thereby provide a feedback loop for the muscle to regulate its own growth and regeneration allowing for adaptation to exercise training. The myokine concept provides a conceptual basis and a whole new paradigm for understanding how muscles communicate with other organs within the muscle itself. New biotechnological patents are published based on the identification of new myokines, and these myokines and their receptors will potentially serve as pharmacological targets for treating muscle diseases, metabolic disorders and other diseases associated with muscle disuse.
Export Options
About this article
Cite this article as:
Henriksen Tora, Green Charlotte and Klarlund Pedersen Bente, Myokines in Myogenesis and Health, Recent Patents on Biotechnology 2012; 6 (3) . https://dx.doi.org/10.2174/1872208311206030167
DOI https://dx.doi.org/10.2174/1872208311206030167 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma
Protein & Peptide Letters Coordinated Expression of Pax-5 and FAK1 in Metastasis
Anti-Cancer Agents in Medicinal Chemistry Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies
Current Medicinal Chemistry Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
Current Drug Targets Structure and Ligand-based Design of P-glycoprotein Inhibitors: A Historical Perspective
Current Pharmaceutical Design Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Knemometry for Assessment of Growth Suppressive Effects of Exogenous Glucocorticoids
Current Pediatric Reviews Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis
Anti-Cancer Agents in Medicinal Chemistry Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study
Anti-Cancer Agents in Medicinal Chemistry Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy Cancer Stem Cells and their Management in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Proteolytic Cleavage of Notch: “HIT and RUN”
Current Molecular Medicine Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy
Clinical Cancer Drugs Novel Derivatives of Benfluron and Dimefluron Synthesis and Anticancer activity
Letters in Drug Design & Discovery Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Recent Progress on Chemical Biology of Pluripotent Stem Cell Selfrenewal, Reprogramming and Cardiomyogenesis
Recent Patents on Regenerative Medicine Biomarkers and Multiple Drug Resistance in Breast Cancer
Current Cancer Drug Targets Germinated Soybean Products as Nutraceutical Compounds in Breadmaking
Current Nutrition & Food Science Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy